Enovix Shares Receive 'Moderate Buy' Rating from Analysts

Analysts cite revenue and earnings beats, operational improvements, but also note near-term guidance disappointment and rising geopolitical risks.

Published on Mar. 2, 2026

Shares of Enovix Corporation (NASDAQ:ENVX) have received a 'Moderate Buy' consensus rating from 10 analysts currently covering the company, according to Marketbeat. While six analysts have assigned a buy rating, three have rated the stock as hold, and one has a sell recommendation. The average 12-month price target is $15.65.

Why it matters

Enovix is a developer of advanced lithium-ion battery cells with a focus on improving energy density, safety, and cycle life compared to conventional graphite-based cells. The company's performance and outlook are closely watched as it aims to capitalize on growing demand across consumer electronics, electric vehicles, and energy storage applications.

The details

Enovix's Q4 2025 results beat expectations, with revenue of $11.3 million (+16% year-over-year) and slightly better-than-forecast earnings. The company highlighted improvements in gross profit and narrower operating losses. However, Q1 2026 revenue guidance of $6.5 million to $7.5 million came in below consensus, weighing on the stock. Analysts have also noted new disclosures around rising geopolitical and trade risks that could impact Enovix's supply chains and margins.

  • Enovix reported Q4 2025 results on March 2, 2026.
  • The company provided Q1 2026 revenue guidance on the earnings call.

The players

Enovix Corporation

An American company that develops and manufactures advanced lithium-ion battery cells with a patented 3D silicon-anode architecture, targeting applications in consumer electronics, electric vehicles, and energy storage.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

Enovix's mixed Q4 results and outlook highlight the challenges the company faces in balancing near-term growth with long-term technological advantages. While analysts remain cautiously optimistic about Enovix's potential, the stock will likely remain volatile as the company navigates supply chain risks and works to achieve profitability.